Literature DB >> 3023310

Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors.

O Yoshie, K Tada, N Ishida.   

Abstract

Highly purified recombinant human tumor necrosis factor (TNF) (molecular mass determined as 17 kilodaltons (kDa) by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and as 36 kDa by Sephadex G-100 gel chromatography) was labeled with 125I to a specific activity of 5 microCi/micrograms without appreciable loss of activity. The binding of 125I-TNF to eighteen human and twelve animal cell lines was examined. The binding varied considerably among different cell lines. In most cell lines, the binding was inhibited up to greater than 90% by the addition of a 100-fold excess of unlabeled TNF. Some human and mouse cell lines showed no significant binding above background levels, suggesting that these cell lines had no receptors for TNF. Among the TNF receptor-positive cell lines, there was no direct correlation between the level of specific TNF binding and the level of sensitivity to the cytotoxic or cytostatic effect of TNF. Some cell lines were sensitive to TNF, whereas others were not affected at all by TNF. The TNF receptor-negative cell lines were also resistant to TNF. Therefore, although the existence of TNF receptor seems to be necessary, it does not alone determine cellular sensitivity to TNF. Scatchard analysis of the binding data revealed that human HeLa S3 and THP-1 had about 50,000 and 10,000 receptors/cell with a dissociation constant (KD) of 0.3-0.5 nM, respectively. Similarly, mouse L-929 and L-M cells had about 5,000 receptors/cell with KD of 3-5 nM. 125I-TNF bound to HeLa S3 cells was rapidly internalized at 37 degrees C, presumably by receptor-mediated endocytosis, and degraded to acid-soluble products. The turnover of TNF receptors on HeLA S3 cells seemed to be rapid, since the level of specific binding quickly decreased after treatment with 100 micrograms/ml of cycloheximide at 37 degrees C with a half-life of about 1.5 h. The crosslinking of the cell-bound 125I-TNF with the use of disuccinimidyl suberate yielded a complex of 105 kDa for HeLa S3 and THP-1 cells, and a complex of 100 kDa for U937 cells. The crosslinking was completely inhibited by the addition of a 100-fold excess of unlabeled TNF. Assuming that the complex was due to a one-to-one association of the dimeric form of TNF (34 kDa) with the receptor, we estimated the molecular size of the human TNF receptor to be 71 kDa for HeLa S3 and THP-1, and 66 kDa for U937.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023310     DOI: 10.1093/oxfordjournals.jbchem.a121744

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  12 in total

1.  Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins.

Authors:  J T Safrit; B Bonavida
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Production of tumour necrosis factor by mastocytoma P815 cells.

Authors:  I Ohno; Y Tanno; K Yamauchi; T Takishima
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

3.  The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor.

Authors:  M Grell; H Wajant; G Zimmermann; P Scheurich
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

4.  Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor.

Authors:  R A Heller; K Song; M A Onasch; W H Fischer; D Chang; G M Ringold
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses.

Authors:  B Thoma; M Grell; K Pfizenmaier; P Scheurich
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

6.  The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation.

Authors:  U Trefzer; M Brockhaus; H Lötscher; F Parlow; A Budnik; M Grewe; H Christoph; A Kapp; E Schöpf; T A Luger
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 7.  Tumor necrosis factor and stroke: role of the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-08-06       Impact factor: 11.685

8.  Fibroblast growth factor increases TNF alpha-mediated prostaglandin E2 production and TNF alpha receptor expression in human fibroblasts.

Authors:  M Candela; S C Barker; L R Ballou
Journal:  Mol Cell Biochem       Date:  1993-03-10       Impact factor: 3.396

9.  Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin.

Authors:  H Gerlach; H Lieberman; R Bach; G Godman; J Brett; D Stern
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  Tumor necrosis factor induces rapid production of 1'2'diacylglycerol by a phosphatidylcholine-specific phospholipase C.

Authors:  S Schütze; D Berkovic; O Tomsing; C Unger; M Krönke
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.